Combination Treatments to Overcome Fibroblast-Associated Resistance to BRAF Inhibitors in Malignant Melanoma Use of the PeggySue Technology to Explore Drug Responses at a Protein level
Tid og sted:,
Seminarrom 4424, Kristine Bonnevies hus
Veileder Lina Prasmickaite, OUS-DNR, Ola Myklebost, IBV
Sensorer: Anders Øverbye, OUS-DNR, Federico Fenaroli, IBV
Publisert17. mars 2017 10:49 - Sist endret17. mars 2017 13:39